Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Han Ah | - |
dc.contributor.author | Chang, Young | - |
dc.contributor.author | Sung, Pil Soo | - |
dc.contributor.author | Yoon, Eileen L. | - |
dc.contributor.author | Lee, Hye Won | - |
dc.contributor.author | Yoo, Jeong-Ju | - |
dc.contributor.author | Lee, Young-Sun | - |
dc.contributor.author | An, Jihyun | - |
dc.contributor.author | Song, Do Seon | - |
dc.contributor.author | Cho, Young Youn | - |
dc.contributor.author | Kim, Seung Up | - |
dc.contributor.author | Kim, Yoon Jun | - |
dc.date.accessioned | 2022-08-18T00:40:12Z | - |
dc.date.available | 2022-08-18T00:40:12Z | - |
dc.date.issued | 2022-07 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61343 | - |
dc.description.abstract | The global burden of chronic liver disease (CLD) is substantial. Due to the limited indication of and accessibility to antiviral therapy in viral hepatitis and lack of effective pharmacological treatment in nonalcoholic fatty liver disease, the beneficial effects of antidiabetics and non–antidiabetics in clinical practice have been continuously investigated in patients with CLD. In this narrative review, we focused on non-antidiabetic drugs, including ursodeoxycholic acid, silymarin, dimethyl4,4’-dimethoxy-5,6,5’,6’-dimethylenedixoybiphenyl-2,2’-dicarboxylate, L-ornithine L-aspartate, branched chain amino acids, statin, probiotics, vitamin E, and aspirin, and summarized their beneficial effects in CLD. Based on the antioxidant, anti-inflammatory properties, and regulatory functions in glucose or lipid metabolism, several non–antidiabetic drugs have shown beneficial effects in improving liver histology, aminotransferase level, and metabolic parameters and reducing risks of hepatocellular carcinoma and mortality, without significant safety concerns, in patients with CLD. Although the effect as the centerpiece management in patients with CLD is not robust, the use of these non-antidiabetic drugs might be potentially beneficial as an adjuvant or combined treatment strategy. | - |
dc.format.extent | 48 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한간학회 | - |
dc.title | Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3350/cmh.2022.0186 | - |
dc.identifier.scopusid | 2-s2.0-85134577966 | - |
dc.identifier.wosid | 000831098900007 | - |
dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, v.28, no.3, pp 425 - 472 | - |
dc.citation.title | Clinical and Molecular Hepatology | - |
dc.citation.volume | 28 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 425 | - |
dc.citation.endPage | 472 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002857582 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | CHAIN AMINO-ACIDS | - |
dc.subject.keywordPlus | CHRONIC HEPATITIS-C | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE GUIDELINES | - |
dc.subject.keywordPlus | CARNITINE-OROTATE COMPLEX | - |
dc.subject.keywordPlus | DOSE URSODEOXYCHOLIC ACID | - |
dc.subject.keywordPlus | PRIMARY BILIARY-CIRRHOSIS | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | ORNITHINE-L-ASPARTATE | - |
dc.subject.keywordPlus | PLUS VITAMIN-E | - |
dc.subject.keywordPlus | BRANCHED-CHAIN | - |
dc.subject.keywordAuthor | Nonalcoholic fatty liver disease | - |
dc.subject.keywordAuthor | Viral hepatitis | - |
dc.subject.keywordAuthor | Cirrhosis | - |
dc.subject.keywordAuthor | Non-antidiabetic drugs | - |
dc.subject.keywordAuthor | Treatment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.